Article

Evaluating algorithmic fairness in the presence of clinical guidelines: the case of atherosclerotic cardiovascular disease risk estimation

2021-11-09

Abstract excerpt

<h4>ABSTRACT</h4> The American College of Cardiology and the American Heart Association guidelines on primary prevention of atherosclerotic cardiovascular disease (ASCVD) recommend using 10-year ASCVD risk estimation models to initiate statin treatment. For guideline-concordant decision making, risk estimates need to be calibrated. However, existing models are often miscalibrated for race, ethnicity, and sex based...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 45b6b28b-a132-5072-9b35-c19a14a39654
DOI: 10.1101/2021.11.08.21266076

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluating algorithmic fairness in the presence of clinical guidelines: the case of atherosclerotic cardiovascular disease risk estimationDOI 10.1101/2021.11.08.21266076Read

Characterizing and Quantifying Performance Heterogeneity in Cardiovascular Risk Prediction Models — A Step Towards Improved Disease Risk AssessmentSemantic proximity Read

Current polygenic risk scores are unlikely to exacerbate unfairness in cardiovascular disease risk predictionSemantic proximity Read

Trade-offs in Cardiovascular Risk Prediction Using Race and Social Determinants of HealthSemantic proximity Read

Performance and Calibration of ASCVD, Framingham, and Globorisk Models in a Large UK Biobank Cohort: A 10-Year Longitudinal Outcome AnalysisSemantic proximity Read

Algorithmic Fairness of Machine Learning Models for Alzheimer’s Disease Progression PredictionSemantic proximity Read

Refocusing Algorithmic Fairness on Feature-Level Bias: A Diagnostic Approach Using Dutch EHR DataSemantic proximity Read

Comprehensive, Transparent, and Fair Machine Learning Models for Hypertension Risk Prediction: Benchmarking With Framingham, External Validation, Individual-Level Analysis, and Equitable Clinical UtilitySemantic proximity Read

Comparative Validation of ASCVD, Framingham Risk Score, Globorisk, and PREVENT for 10-Year Cardiovascular Risk Prediction in the UK BiobankSemantic proximity Read

External validation and comparison of PREVENT and SCORE2 atherosclerotic cardiovascular risk scores in the MASHAD cohort studySemantic proximity Read

OPPORTUNISTIC ASSESSMENT OF CARDIOVASCULAR RISK USING AI-DERIVED STRUCTURAL AORTIC AND CARDIAC PHENOTYPES FROM NON-CONTRAST CHEST COMPUTED TOMOGRAPHYSemantic proximity Read

Differences in estimates for ten-year risk of cardiovascular disease in Black versus white persons with identical risk factor profiles using pooled cohort equationsSemantic proximity Read

Assessing Phenotype Definitions for Algorithmic Fairness.Semantic proximity Read